Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Divestments (2018 - 2021)

Pediatrix Medical (MD) reported Divestments of $2.4 million for Q1 2021, up 180.1% year-over-year from $839000.0 in Q1 2020, and down 99.73% on a QoQ basis from $870.8 million in Q4 2020.

Pediatrix Medical (MD) has 4 years of Divestments data on file, last reported at $2.4 million in Q1 2021.

  • Quarterly Divestments rose 180.1% year-over-year to $2.4 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $2.4 million (down 99.73% YoY) and the FY2021 annual result came in at $2.4 million, down 99.73% from the prior year.
  • Divestments eased to $2.4 million in Q1 2021 per MD's latest filing, from $870.8 million in the prior quarter.
  • Across five years, Divestments topped out at $870.8 million in Q4 2020 and bottomed at -$80.9 million in Q4 2018.
  • The 4-year median for Divestments is $2.4 million (2021), against an average of $107.9 million.
  • Peak annual rise in Divestments reached 401.92% in 2020, while the deepest fall reached 71.37% in 2020.
  • Tracing MD's Divestments over 4 years: stood at -$80.9 million in 2018, then jumped by 314.53% to $173.5 million in 2019, then soared by 401.92% to $870.8 million in 2020, then tumbled by 99.73% to $2.4 million in 2021.
  • Per Business Quant, the three latest MD Divestments figures stand at $2.4 million (Q1 2021), $870.8 million (Q4 2020), and -$6.0 million (Q3 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 3.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 2.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 109,000.00
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 14.30 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 1.44 Mn
10 Pediatrix Medical 1.74 Bn 1.41 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2021 2.35 Mn
Dec 31, 2020 870.78 Mn
Sep 30, 2020 -5.95 Mn
Jun 30, 2020 8.19 Mn
Mar 31, 2020 839,000.00
Dec 31, 2019 173.49 Mn
Sep 30, 2019 -20.79 Mn
Dec 31, 2018 -80.87 Mn
Mar 31, 2018 22.76 Mn